Hostname: page-component-77f85d65b8-8v9h9 Total loading time: 0 Render date: 2026-03-29T04:38:05.989Z Has data issue: false hasContentIssue false

Do common metrics add value? Perspectives from NIH Clinical and Translational Science Awards (CTSA) Consortium hubs

Published online by Cambridge University Press:  14 December 2020

Lisa C. Welch*
Affiliation:
Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
Andrada Tomoaia-Cotisel
Affiliation:
RAND Corporation, Santa Monica, CA, USA
Hong Chang
Affiliation:
Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
Peter Mendel
Affiliation:
RAND Corporation, Santa Monica, CA, USA
Jason M. Etchegaray
Affiliation:
RAND Corporation, Santa Monica, CA, USA
Nabeel Qureshi
Affiliation:
RAND Corporation, Santa Monica, CA, USA
Marguerite Fenwood-Hughes
Affiliation:
Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA
Anshu Parajulee
Affiliation:
Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA
Harry P. Selker
Affiliation:
Tufts Clinical and Translational Science Institute, Tufts University, Boston, MA, USA Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, USA
*
Address for correspondence: L. C. Welch, PhD, Tufts Medical Center, 800 Washington Street, Box 63, Boston, MA 02111, USA. Email: LWelch2@TuftsMedicalCenter.org
Rights & Permissions [Opens in a new window]

Abstract

Introduction:

The Clinical and Translational Science Awards (CTSA) Consortium, a network of academic health care institutions with CTSA hubs, is charged with improving the national clinical and translational research enterprise. The CTSA Consortium and the NIH National Center for Advancing Translational Sciences implemented the Common Metrics Initiative comprised of standardized metrics and a shared performance improvement framework. This article summarizes hubs’ perspectives on its value during the initial implementation.

Methods:

The value was assessed across 58 hubs. Survey items assessed change in perceived ability to manage performance and advance clinical and translational science. Semi-structured interviews elicited hubs’ perspectives on meaningfulness and value-added of the Common Metrics Initiative and hubs’ recommendations.

Results:

Hubs considered their abilities to manage performance to have improved, but there was no change in perceived ability to advance clinical and translational science. The initiative added value by providing a formal structured process, enabling strategic conversations, facilitating improvements in processes, providing an external impetus for improvement, and providing justification for funds invested. Hubs were concerned about the usefulness of the metrics chosen and whether the value-added was sufficient relative to the effort required. Hubs recommended useful benchmarking, disseminating best practices and promoting peer-to-peer learning, and expanding the use of data to inform the initiative.

Conclusions:

Implementing Common Metrics and a performance improvement framework yielded concrete short-term benefits, but concerns about usefulness remained, particularly considering the effort required. The Common Metrics Initiative should focus on facilitating cross-hub collaboration around metrics that address high-priority impact areas for individual hubs and the Consortium.

Information

Type
Research Article
Creative Commons
Creative Common License - CCCreative Common License - BYCreative Common License - NCCreative Common License - ND
This is an Open Access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is unaltered and is properly cited. The written permission of Cambridge University Press must be obtained for commercial re-use or in order to create a derivative work.
Copyright
© The Association for Clinical and Translational Science 2020
Figure 0

Table 1. Survey items measuring self-assessed ability to manage performance

Figure 1

Table 2. Scoring rubric used in interview sampling: completion of Common Metrics and performance improvement activities

Figure 2

Table 3. Semi-structured interviews: final sample of hubs (N = 30)

Figure 3

Fig. 1. Comparison of self-assessed ability to manage performance and facilitate clinical and translational science during the initial implementation of Common Metrics. *One hub did not respond to the second follow-up survey. A second hub was dropped from this analysis due to missing data; **p = 0.02; ***p = 0.01; ϵ = 0–100 scale; higher score reflects a better self-assessment.

Figure 4

Table 4. Self-assessed ability to manage performance during initial implementation of Common Metrics

Figure 5

Table 5. Hub recommendations for Common Metrics implementation